Elderly patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) have an increased risk of sedation related complications during the procedure. To determine whether nasal oxygen supplementation (2 I/min) reduces these risks, half of 66 patients aged over 60 undergoing ERCP using minimal midazolam sedation alone were randomised to receive nasal oxygen. The arterial oxygen saturation and pulse rate of all patients were monitored by pulse oximetry before and during the procedure. Only three patients in the oxygen supplemented group (n=33) required any form of intervention for hypoxia compared with six in the control group (n=33). Comparison of mean arterial oxygen saturation between the groups showed significantly higher levels in the nasal oxygen group throughout the procedure. Pulse rate comparisons showed no significant difference from control group values, both groups had short periods of significant tachycardia. We conclude that minimal sedation with midazolam alone still produces hypoxia during ERCP in a substantial number of elderly patients. Nasal oxygen supplementation increases the level of patient oxygenation and reduces the need for intervention, but does not reduce tachycardia in the elderly patient. Because hyoscine may be a significant factor contributing to the tachycardia, sparing rather than routine use of this agent is advisable.
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Periods of hypoxia were common in the control group, but greatly reduced in patients receiving oxygen. SaO2 was significantly higher throughout the procedure in patients given oxygen, but there was no difference in pulse rate between the two groups. Some degree of tachycardia was experienced by all patients during the procedure and approximately 23% of patients in each group showed appreciable tachycardia during the procedure. These findings are similar to those reported by previous workers examining hypoxia during ERCP in patients undergoing the procedure after benzodiazepine sedation with narcotic agents.' I This tachycardia may be caused by the hyoscine butylbromide premedication as tachycardia was often apparent in patients after hyoscine administration before intubation. This probably reflects the recognised antimuscarinic properties of this drug. 12 Hyoscine butylbromide is often necessary during ERCP, but should be used in as low a dose as possible and only when really needed rather than routinely.
In conclusion, hypoxia commonly occurs in elderly ERCP patients even with minimal sedation without narcotics. Nasal oxygen supplementation significantly reduces this problem and should be routinely used in patients over the age of 60 undergoing ERCP as this reduces the sedation risks of the procedure. It was disappointing that it had no significant effect on the tachycardia, but this may be helped by more sparing use of hyoscine butylbromide. The results of this study support the guide lines recently published by the British Society of Gastroenterology. I3
